← Leaderboards
Rita Mukhtar
University Of California, San Francisco
$1,277,220
Attributed
$1,277,220
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $255.4K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,277,220 · 1
By mechanism
K08$1,277,220 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Daniel B Vigneron$43,424,992
- Bruce L Miller$34,542,477
- Diane V Havlir$125,216,731
- William A Weiss$31,543,847
- Nola M. Hylton$19,153,972
Others in their field
Other Emerging Leaders on “Drug Combinations”
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Emmanuel Aja Oga · Research Triangle Institute$16,110,065
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$15,277,646
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
Drug CombinationsDisease-Free SurvivalDesignDiagnosisCytotoxic ChemotherapyBiological MarkersData SetBreast Cancer PatientDetectionCancer Clinical TrialAffectCessation Of LifeCharacteristicsChemotherapyBiomarker DevelopmentClinical InvestigatorClinically RelevantClinical PracticeCancer BurdenClinical ResearchClinical TrialsCohortCareerDuct (Organ) Structure
Grant awards (5)
Identifying responders to chemotherapy in invasive lobular carcinoma of the breast: development of a multivariable clinical prediction tool$255,444
K08 · FY2025 · CA · contact PI
Identifying responders to chemotherapy in invasive lobular carcinoma of the breast: development of a multivariable clinical prediction tool$255,444
K08 · FY2024 · CA · contact PI
Identifying responders to chemotherapy in invasive lobular carcinoma of the breast: development of a multivariable clinical prediction tool$255,444
K08 · FY2023 · CA · contact PI
Identifying responders to chemotherapy in invasive lobular carcinoma of the breast: development of a multivariable clinical prediction tool$255,444
K08 · FY2022 · CA · contact PI
Identifying responders to chemotherapy in invasive lobular carcinoma of the breast: development of a multivariable clinical prediction tool$255,444
K08 · FY2021 · CA · contact PI